These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36928879)

  • 21. Antiphospholipid antibody syndrome.
    Lim W
    Hematology Am Soc Hematol Educ Program; 2009; ():233-9. PubMed ID: 20008203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging Therapies in Antiphospholipid Syndrome.
    Hubben A; McCrae KR
    Transfus Med Rev; 2022 Oct; 36(4):195-203. PubMed ID: 36272841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
    Sayar Z; Moll R; Isenberg D; Cohen H
    Thromb Res; 2021 Feb; 198():213-221. PubMed ID: 33485122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not Available].
    Hansen RS; Larsen JB; Vinholt PJ; Voss A; Abildgaard A
    Ugeskr Laeger; 2024 May; 186(21):. PubMed ID: 38847311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiphospholipid antibodies--risk factors for venous thromboembolism and arterial thrombosis].
    Zawilska K
    Pol Arch Med Wewn; 2007; 117 Suppl():41-5. PubMed ID: 18778019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Coronary Syndromes in Antiphospholipid Syndrome-above Suspicion: A Systematic Review.
    Nevras V; Milaras N; Katsioulis C; Sotiriou Z; Tsalamandris S; Gkounti G; Skevos S
    Curr Probl Cardiol; 2023 Mar; 48(3):101503. PubMed ID: 36402221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiphospholipid antibodies: what is new in 2022].
    Melicine S; Gendron N; Darnige L; Mauge L
    Ann Biol Clin (Paris); 2022 Jul; 80(4):333-343. PubMed ID: 36099353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Myocardial Infarction Due to Antiphospholipid Syndrome - Case Report and Review of the Literature.
    Semczuk-Kaczmarek K; Platek AE; Ryś-Czaporowska A; Szymanski FM; Filipiak KJ
    Curr Probl Cardiol; 2021 Mar; 46(3):100552. PubMed ID: 32216971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat?
    Calcaterra I; Tufano A; Lupoli R; Iannuzzo G; Emmi G; Di Minno MND
    Pol Arch Intern Med; 2021 Feb; 131(2):161-170. PubMed ID: 32491304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
    Sayar Z; Burke S; Mittal P; Cohen H
    Lupus; 2022 Oct; 31(12):1485-1490. PubMed ID: 36074077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Insights into the Use of Direct Oral Anticoagulants in Non-high Risk Thrombotic APS Patients: Literature Review and Subgroup Analysis from a Meta-analysis.
    Dufrost V; Darnige L; Reshetnyak T; Vorobyeva M; Jiang X; Yan XX; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Curr Rheumatol Rep; 2020 May; 22(7):25. PubMed ID: 32436109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
    Cohen H; Efthymiou M; Gates C; Isenberg D
    Semin Thromb Hemost; 2018 Jul; 44(5):427-438. PubMed ID: 28196381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement and the antiphospholipid syndrome.
    Lim W
    Curr Opin Hematol; 2011 Sep; 18(5):361-5. PubMed ID: 21730831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
    Cohen H; Cuadrado MJ; Erkan D; Duarte-Garcia A; Isenberg DA; Knight JS; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Williams DJ; Willis R; Woller SC; Andrade D
    Lupus; 2020 Oct; 29(12):1571-1593. PubMed ID: 33100166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.